|
Pegaspargase Clinical Trials
13 actively recruiting trials across 4 locations
Also known as: L-Asparaginase with Polyethylene Glycol, Oncaspar, Oncaspar-IV, PEG, PEG-Asparaginase +6 more
Pipeline
Phase 1: 2Phase 2: 5Phase 3: 4Phase 4: 1Phase 1/2: 1
Top Sponsors
- Children's Oncology Group3
- National Cancer Institute (NCI)2
- Wei Zhao1
- University of Chicago1
- Martin Schrappe1
Indications
- Cancer13
- B Acute Lymphoblastic Leukemia4
- T Acute Lymphoblastic Leukemia2
- Recurrent B Acute Lymphoblastic Leukemia2
- T-lymphoblastic Lymphoma2
Other5 trials
Birmingham, Alabama5 trials
Phase 3
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Children's Hospital of Alabama
Phase 2
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Children's Hospital of Alabama
Phase 3
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Children's Hospital of Alabama
Phase 2
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Children's Hospital of Alabama
Phase 3
Duarte, California1 trial
Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
City of Hope Medical Center
Phase 1
Chicago, Illinois1 trial
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
University of Chicago Medical Center
Phase 1
Houston, Texas1 trial
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
M D Anderson Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.